Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ardent Health (ARDT) Shares Outstanding (Diluted Average): 2023-2025

Historic Shares Outstanding (Diluted Average) for Ardent Health (ARDT) over the last 3 years, with Q3 2025 value amounting to $141.2 million.

  • Ardent Health's Shares Outstanding (Diluted Average) rose 268.94% to $141.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $141.2 million, marking a year-over-year increase of 268.94%. This contributed to the annual value of $132.7 million for FY2024, which is 525.65% up from last year.
  • Per Ardent Health's latest filing, its Shares Outstanding (Diluted Average) stood at $141.2 million for Q3 2025, which was up 268.94% from $141.5 million recorded in Q2 2025.
  • Ardent Health's 5-year Shares Outstanding (Diluted Average) high stood at $141.5 million for Q2 2025, and its period low was $126.1 million during Q2 2023.
  • For the 3-year period, Ardent Health's Shares Outstanding (Diluted Average) averaged around $132.4 million, with its median value being $129.4 million (2023).
  • In the last 5 years, Ardent Health's Shares Outstanding (Diluted Average) changed by 0.0% in 2024 and then soared by 1221.29% in 2025.
  • Over the past 3 years, Ardent Health's Shares Outstanding (Diluted Average) (Quarter) stood at $126.1 million in 2023, then increased by 5.26% to $132.7 million in 2024, then increased by 6.4% to $141.2 million in 2025.
  • Its last three reported values are $141.2 million in Q3 2025, $141.5 million for Q2 2025, and $140.7 million during Q1 2025.